Predicted protein targets (top 2)
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL3966833 | 0.86 | PADI4 (0.34) | PADI4ERN1 | |
| SCHEMBL809345 | 0.84 | VCP (0.33) | — | |
| SCHEMBL419449 | 0.81 | VCP (0.38) | — | |
| SCHEMBL1808857 | 0.78 | VCP (0.36) | — | |
| SCHEMBL29933309 | 0.78 | ERN1 (0.37) | ERN1 | |
| SCHEMBL22042201 | 0.77 | MEN1 (0.32) | — | |
| SCHEMBL23360936 | 0.76 | MEN1 (0.36) | PADI4ERN1 | |
| SCHEMBL24834495 | 0.75 | — | — | |
| SCHEMBL1808693 | 0.74 | MEN1 (0.35) | — | |
| SCHEMBL1809301 | 0.74 | VCP (0.38) | — |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 28 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| WO-2024181874-A1 | METHOD FOR THE PREPARATION OF RHODOL DERIVATIVES POSSESSING THREE FLUORINE SUBSTITUENTS IN POSITIONS 1, 2 AND 4 AND COMPOUNDS OBTAINED BY THIS METHOD | Instytut Chemii Organicznej Polskiej Akademii Nauk (PL) | 2024-09-06 | — | — | WO | claimed |
| US-12595275-B2 | Fluorine-containing compound and anti-cancer medical use thereof | ASCENTAWITS PHARMACEUTICALS, LTD. (CN) | 2026-04-07 | — | — | US | disclosed |
| EP-3971194-B1 | FLUORINE-CONTAINING COMPOUND AND ANTI-CANCER MEDICAL USE THEREOF | ASCENTAWITS PHARMACEUTICALS LTD (CN) | 2025-12-03 | — | — | EP | disclosed |
| EP-4598933-A1 | PHOSPHORAMIDATE COMPOUNDS AND USES THEREOF | Allorion Therapeutics Inc (US) | 2025-08-13 | — | — | EP | disclosed |
| CN-119968377-A | Phosphoramidate compounds and uses thereof | 安锐生物医药公司 | 2025-05-09 | — | — | CN | disclosed |
| CN-118834240-A | Fluorine-containing compound and anticancer medical application | 深圳艾欣达伟医药科技有限公司 | 2024-10-25 | — | — | CN | disclosed |
| WO-2024181874-A1 | METHOD FOR THE PREPARATION OF RHODOL DERIVATIVES POSSESSING THREE FLUORINE SUBSTITUENTS IN POSITIONS 1, 2 AND 4 AND COMPOUNDS OBTAINED BY THIS METHOD | Instytut Chemii Organicznej Polskiej Akademii Nauk (PL) | 2024-09-06 | — | — | WO | disclosed |
| CN-113853379-B | Fluorine-containing compound and anticancer medical application | 深圳艾欣达伟医药科技有限公司 | 2024-04-30 | — | — | CN | disclosed |
| WO-2024078392-A1 | PHOSPHORAMIDATE COMPOUNDS AND USES THEREOF | ANRUI BIOMEDICAL TECHNOLOGY (GUANGZHOU) CO., LTD. (CN) | 2024-04-18 | — | — | WO | disclosed |
| US-20220119429-A1 | FLUORINE-CONTAINING COMPOUND AND ANTI-CANCER MEDICAL USE THEREOF | ASCENTAWITS PHARMACEUTICALS, LTD. (CN) | 2022-04-21 | — | — | US | disclosed |
| WO-2020228685-A1 | FLUORINE-CONTAINING COMPOUND AND ANTI-CANCER MEDICAL USE THEREOF | 深圳艾欣达伟医药科技有限公司 | 2020-11-19 | — | — | WO | disclosed |
| US-9984878-B2 | Resist under layer film composition and patterning process | SHIN-ETSU CHEMICAL CO., LTD. (JP) | 2018-05-29 | — | — | US | disclosed |
| US-9884832-B2 | Inhibitors targeting drug-resistant influenza A | THE TRUSTEES OF THE UNIVERSITY OF PENNSYLVANIA (US) | 2018-02-06 | — | — | US | disclosed |
| US-20160342088-A1 | RESIST UNDER LAYER FILM COMPOSITION AND PATTERNING PROCESS | SHIN-ETSU CHEMICAL CO., LTD. (JP) | 2016-11-24 | — | — | US | disclosed |
| US-20150191439-A1 | INHIBITORS TARGETING DRUG-RESISTANT INFLUENZA A | NATIONAL INSTITUTES OF HEALTH (NIH), U.S. DEPT. OF HEALTH AND HUMAN SERVICES (DHHS), U.S. GOVERNMENT | 2015-07-09 | — | — | US | disclosed |
| WO-2013086131-A1 | INHIBITORS TARGETING DRUG-RESISTANT INFLUENZA A | THE TRUSTEES OF THE UNIVERSITY OF PENNSYLVANIA (US) | 2013-06-13 | — | — | WO | disclosed |
| US-7964878-B2 | Light emitting polymer devices using self-assembled monolayer structures | HCF PARTNERS, LP (US) | 2011-06-21 | — | — | US | disclosed |
| US-20100134052-A1 | Light Emitting Polymer Devices Using Self-Assembled Monolayer Structures | HCF PARTNERS, L.P. (US) | 2010-06-03 | — | — | US | disclosed |
| WO-2006116584-A2 | LIGHT EMITTING POLYMER DEVICES USING SELF-ASSEMBLED MONOLAYER STRUCTURES | DYNAMIC ORGANIC LIGHT, INC. (US) | 2006-11-02 | — | — | WO | disclosed |
| US-4717760-A | HEAT AND WATER RESISTANCE WHEN CURED | THE DOW CHEMICAL COMPANY (US) | 1988-01-05 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (4 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-12595275-B2 | Fluorine-containing compound and anti-cancer medical use thereof | BCOR, BCL6, CCR6 | PADI4 4000/4885ERN1 2232/4885 |
| US-20150191439-A1 | INHIBITORS TARGETING DRUG-RESISTANT INFLUENZA A | HAVCR2, HDLBP, HSP90B1 | PADI4 1811/4885ERN1 1739/4885 |
| US-20220119429-A1 | FLUORINE-CONTAINING COMPOUND AND ANTI-CANCER MEDICAL USE THEREOF | FLI1, FOLR2, FOLR1 | PADI4 3019/4885ERN1 3306/4885 |
| US-20100134052-A1 | Light Emitting Polymer Devices Using Self-Assembled Monolayer Structures | CLTB, CYBA, CLTA | PADI4 900/4885ERN1 3393/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.